No to Acta, yes to the right to health

The United Nations Special Rapporteur on the right to health, Anand Grover, praised the European Parliament’s rejection of the Anti-Counterfeiting Trade Agreement (ACTA) on July 4 as a step in the right direction to ensure continued access to affordable and essential drugs and medication essential for the fulfillment of the right to health

Photo: No to Acta, yes to the right to health
Photo: No to Acta, yes to the right to health

According to Grover, ACTA’s defeat in Europe was a welcome blow to the flawed agreement which had failed to address numerous concerns related to access to medicines. In July 2011, the UN Human Rights Council requested the Special Rapporteur to study existing challenges with regard to access to medicines, ways to overcome them and good practices. He will present the study to the Council in June 2013

10.07.2012

More on the subject:
Read all latest stories

Related articles

Photo

News • GMAI for cancer treatment

Generalist Medical AI: Experts propose legal guardrails

Generalist Medical Artificial Intelligence (GMAI) models pose a significant challenge to current regulatory frameworks. Experts discuss how regulation of these models could work in the future.

Photo

News • Appeal for better approval conditions

AI in personalised cancer medicine: “A fundamental change is needed”

AI technology holds promise for personalised cancer therapies. However, rigid and slow approval requirements impede its introduction, say experts – and point out how this might be changed.

Photo

News • Accelerated sample analysis

Digital pathology cleared for use in cancer screening programmes

Digital pathology brings benefits for sample management and optimisation, lets pathologists work on samples remotely: The UK Government has now approved the use of the technique for cancer samples.

Subscribe to Newsletter